Search
Returning search results with filters:
Remove filter for
Issue: Health products
Remove filter for
Type: Alert
Clear all
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 11 of 11 items.
… (the Canadian importer and distributor) is distributing COVID-19 Vaccine Moderna doses directly to vaccination locations where …
AlertHealth professional risk communication | 2021-02-22
… hand sanitizers Issue Health products - Product safety COVID What to do Stop using the identified product lots … printed on the label Product recalled by company 2021-04-19 Sani-Derm May contain unacceptable ingredient, ethyl … seek medical help immediately. To help limit the spread of COVID-19, wash your hands often with soap and water for at …
AlertPublic advisory | 2022-07-11
… Last updated 2022-06-06 Summary Product SPIKEVAX (elasomeran) (0.10 mg/mL) Issue Health products - … products - Packaging Health products - Product safety COVID What to do See Key Messages below Audience Health … of SPIKEVAX (0.1 0 mg/mL, 2.5 mL multidose vial), Moderna will distribute vaccine product with English-only …
AlertHealth professional risk communication | 2022-06-06
… Last updated 2022-01-11 Summary Product SPIKEVAX (elasomeran) COVID-19 Vaccine Issue Health products - Labelling Health … Strategies Inc. Vials of SPIKEVAX/ COVID-19 Vaccine Moderna, currently on the market, with printed expiry dates …
AlertHealth professional risk communication | 2022-01-11
… Brand(s) SPIKEVAX Last updated 2021-11-10 Summary Product SPIKEVAX (elasomeran) COVID-19 Vaccine Issue Health products - Supply What to do … use. Key messages On December 23, 2020, COVID-19 Vaccine Moderna (DIN 02510014) was authorized in accordance with the …
AlertHealth professional risk communication | 2021-11-10
… (POUs). Pfizer is initially distributing Pfizer-BioNTech COVID-19 Vaccine doses directly to POUs, vaccination locations … 9, 2020, Pfizer-BioNTech COVID-19 Vaccine (COVID-19 mRNA Vaccine) (DIN 02509210) was authorized in accordance …
AlertHealth professional risk communication | 2020-12-12
… Sale and Advertising of Drugs for Use in Relation to COVID-19 . Casirivimab and imdevimab, to be administered together, … treatment of mild to moderate coronavirus disease 2019 (COVID-19), confirmed by direct SARS-CoV-2 viral testing, in …
AlertHealth professional risk communication | 2021-07-30
… N95 respirators, as they may not protect consumers against COVID-19. What to do: Check whether your N95 respirator has been … stop using it as it may not protect you against COVID-19. What you should do Media enquiries Public enquiries …
AlertPublic advisory | 2020-04-14
… Sale and Advertising of Drugs for Use in Relation to COVID-19 . Bamlanivimab is indicated for the treatment of adults … patients 12 years of age or older with mild to moderate COVID-19, who weigh at least 40 kg and who are at high risk …
AlertHealth professional risk communication | 2020-12-18
… Last updated 2021-06-14 Summary Product Moderna COVID-19 Vaccine Issue Health products - Labelling Health … (from 7 months to 9 months) for certain lots of the SPIKEVAX (previously COVID-19 Moderna vaccine). This …
AlertHealth professional risk communication | 2021-06-14
… and have health concerns To help limit the spread of COVID-19, wash your hands often with soap and water for at least 20 … (DIN) but have been accepted for use in Canada during the COVID-19 pandemic Report any health product adverse events …
AlertPublic advisory | 2021-03-24